NCT07403721
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07403721
Title AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Tennessee Oncology PLLC RECRUITING Nashville Tennessee 37203 United States Details
Next Oncology - Dallas RECRUITING Irving Texas 75039 United States Details
Calvary Mater Newcastle Hospital RECRUITING Waratah New South Wales 2298 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 1Z5 Canada Details
Zhongshan Hospital Fudan University RECRUITING Shanghai Shanghai Municipality 200032 China Details
Aichi Cancer Center RECRUITING Nagoya Aichi-ken 464-8681 Japan Details
National Cancer Center Hospital East RECRUITING Kashiwa-shi Chiba 277-8577 Japan Details
National Cancer Center Hospital RECRUITING Chuo-ku Tokyo 104-0045 Japan Details
The Cancer Institute Hospital of Japanese Foundation for Cancer Research RECRUITING Koto-ku Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field